Literature DB >> 22456625

MiR-125 in normal and malignant hematopoiesis.

L Shaham1, V Binder, N Gefen, A Borkhardt, S Izraeli.   

Abstract

MiR-125 is a highly conserved microRNA throughout many different species from nematode to humans. In humans, there are three homologs (hsa-miR-125b-1, hsa-miR-125b-2 and hsa-miR-125a). Here we review a recent research on the role of miR-125 in normal and malignant hematopoietic cells. Its high expression in hematopoietic stem cells (HSCs) enhances self-renewal and survival. Its expression in specific subtypes of myeloid and lymphoid leukemias provides resistance to apoptosis and blocks further differentiation. A direct oncogenic role in the hematopoietic system has recently been demonstrated by several mouse models. Targets of miR-125b include key proteins regulating apoptosis, innate immunity, inflammation and hematopoietic differentiation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22456625     DOI: 10.1038/leu.2012.90

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  90 in total

1.  An extensive network of TET2-targeting MicroRNAs regulates malignant hematopoiesis.

Authors:  Jijun Cheng; Shangqin Guo; Suning Chen; Stephen J Mastriano; Chaochun Liu; Ana C D'Alessio; Eriona Hysolli; Yanwen Guo; Hong Yao; Cynthia M Megyola; Dan Li; Jun Liu; Wen Pan; Christine A Roden; Xiao-Ling Zhou; Kartoosh Heydari; Jianjun Chen; In-Hyun Park; Ye Ding; Yi Zhang; Jun Lu
Journal:  Cell Rep       Date:  2013-10-10       Impact factor: 9.423

2.  miR-125b controls monocyte adaptation to inflammation through mitochondrial metabolism and dynamics.

Authors:  Isabelle Duroux-Richard; Christine Roubert; Meryem Ammari; Jessy Présumey; Joachim R Grün; Thomas Häupl; Andreas Grützkau; Charles-Henri Lecellier; Valérie Boitez; Patrice Codogno; Johanna Escoubet; Yves-Marie Pers; Christian Jorgensen; Florence Apparailly
Journal:  Blood       Date:  2016-10-04       Impact factor: 22.113

3.  Tumorigenesis in Down's syndrome: big lessons from a small chromosome.

Authors:  Dean Nižetić; Jürgen Groet
Journal:  Nat Rev Cancer       Date:  2012-09-21       Impact factor: 60.716

4.  NF-κB-dependent microRNA-125b up-regulation promotes cell survival by targeting p38α upon ultraviolet radiation.

Authors:  Guangyun Tan; Jixiao Niu; Yuling Shi; Hongsheng Ouyang; Zhao-Hui Wu
Journal:  J Biol Chem       Date:  2012-07-31       Impact factor: 5.157

5.  An aberrant microRNA signature in childhood T-cell lymphoblastic lymphoma affecting CDKN1B expression, NOTCH1 and growth factor signaling pathways.

Authors:  L Mussolin; A B Holmes; C Romualdi; G Sales; E S G D'Amore; M Ghisi; M Pillon; A Rosolen; K Basso
Journal:  Leukemia       Date:  2014-04-14       Impact factor: 11.528

6.  Association between miR-125a rs12976445 and survival in breast cancer patients.

Authors:  Lianghe Jiao; Jiaxin Zhang; Yuanyuan Dong; Bensong Duan; Hong Yu; Haihui Sheng; Junxing Huang; Hengjun Gao
Journal:  Am J Transl Res       Date:  2014-11-22       Impact factor: 4.060

7.  MiR-125b attenuates human hepatocellular carcinoma malignancy through targeting SIRT6.

Authors:  Shi Song; Yuxia Yang; Minghui Liu; Boya Liu; Xin Yang; Miao Yu; Hao Qi; Mengmeng Ren; Zhe Wang; Junhua Zou; Feng Li; Xiaojuan Du; Hongquan Zhang; Jianyuan Luo
Journal:  Am J Cancer Res       Date:  2018-06-01       Impact factor: 6.166

Review 8.  MicroRNAs: history, biogenesis, and their evolving role in animal development and disease.

Authors:  M Bhaskaran; M Mohan
Journal:  Vet Pathol       Date:  2013-09-17       Impact factor: 2.221

9.  Comparative effects of diet and carcinogen on microRNA expression in the stem cell niche of the mouse colonic crypt.

Authors:  Manasvi S Shah; Eunjoo Kim; Laurie A Davidson; Jason M Knight; Roger S Zoh; Jennifer S Goldsby; Evelyn S Callaway; Beyian Zhou; Ivan Ivanov; Robert S Chapkin
Journal:  Biochim Biophys Acta       Date:  2015-10-19

10.  Identification of candidate genes encoding an LDL-C QTL in baboons.

Authors:  Genesio M Karere; Jeremy P Glenn; Shifra Birnbaum; Sassan Hafizi; David L Rainwater; Michael C Mahaney; John L VandeBerg; Laura A Cox
Journal:  J Lipid Res       Date:  2013-04-17       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.